Every ThryveOn ingredient is selected from peer-reviewed human clinical evidence and dosed at the levels studied in those trials — not token amounts. No proprietary blends. No hidden doses.
Every ingredient category backed by multiple independent human trials. Judge the proof yourself — all paper counts sourced from PubMed for the listed ingredients at comparable doses.
| Ingredient category | Key ingredients in ThryveOn | Clinical papers | Outcomes measured | Common findings |
|---|---|---|---|---|
| 🧠 Cognitive & Adaptogenic Stack | ||||
| Nootropics & Neural Activators | Lion's Mane 700mg, L-Tyrosine 600mg, ALCAR 500mg, L-Theanine 150mg, CDP-Choline 100mg, Panax Ginseng 100mg | 120+ | Cognitive performance, memory, reaction time, NGF, dopamine/acetylcholine markers | Improved cognitive scores & working memory; NGF stimulation confirmed in human RCTs; reduced mental fatigue under stress |
| Adaptogens & Stress Modulators | Ashwagandha 250mg (≥5% withanolides), Rhodiola Rosea 200mg (3% rosavins), Saffron 30mg, Holy Basil 100mg, Schisandra 100mg | 90+ | Serum cortisol, PSS anxiety scores, HRV, mood ratings, sleep quality | 27–30% cortisol reduction; Saffron comparable to low-dose SSRI in mild depression RCTs; significant burnout reduction within 1 week |
| ⚡ Cellular Energy & Longevity Stack | ||||
| Mitochondrial Optimisers | CoQ10 100mg, PQQ 5mg, ALCAR 500mg, Taurine 500mg, Glycine 500mg, Magnesium Bisglycinate 200mg | 200+ | ATP synthesis, mitochondrial biogenesis (PGC-1α), cellular energy, exercise capacity, cardiac output | CoQ10 reduces cardiovascular events (Q-SYMBIO, n=420); PQQ upregulates mitochondrial biogenesis; Taurine supports VO₂max; Mg-Bisglycinate ~40% bioavailability vs ~4% oxide; Glycine improves sleep quality (Bannai 2012) |
| Active-Form B Vitamins | Methylcobalamin B12 50mcg, 5-MTHF Folate 400mcg, B6 (P-5-P), Riboflavin, Niacin | 95+ | Homocysteine, energy metabolism, neurological function, methylation markers | Methylcobalamin bypasses hepatic conversion; 5-MTHF bypasses MTHFR variants affecting ~40% of North Americans; consistently lowers homocysteine |
| 🦠 Gut Health & Microbiome Stack | ||||
| Probiotics, Prebiotics & Gut Support | LactoSpore® (B. coagulans MTCC 5856) 5B CFU, L. acidophilus 3B CFU, B. longum 2B CFU, PHGG 1,000mg, Acacia Fibre 400mg, Bromelain 100mg, Ginger 50mg | 320+ | IBS symptom scores, bloating, microbiome diversity, gut-brain axis markers, intestinal permeability | Reduced bloating & gas; improved stool regularity; L-Glutamine reduces intestinal permeability; gut-brain axis improvement confirmed in anxiety RCT (Pinto-Sanchez 2017) |
| 🛡️ Immunity & Antioxidant Stack | ||||
| Immune Activators & Fat-Soluble Vitamins | Vitamin C 700mg, Elderberry 100mg (≥15% anthocyanins), Zinc Bisglycinate 8mg, Selenium 55mcg, Vitamin D3 2,000 IU, K2 MK-7 100mcg | 460+ | Cold/infection incidence and duration, NK cell activity, CRP, IL-6, bone density, cardiovascular markers | Vitamin C reduces cold duration 8–14%; Elderberry reduces upper respiratory symptoms by 2 days; D3 reduces respiratory infection risk 12–70%; D3 regulates 1,000+ genes; 32% of Canadians are D-deficient (CHMS) |
| 🦴 Joint, Recovery & Anti-Inflammatory Stack | ||||
| Joint & Connective Tissue | MSM 1,000mg, Boswellia Serrata 100mg (20% AKBA), Curcumin 50mg (95% curcuminoids + ar-turmerone), Black Pepper 3mg | 150+ | VAS pain scores, WOMAC joint function index, TNF-α, IL-1β, 5-LOX inhibition, collagen synthesis | MSM 43% pain reduction (Kim 2006); Boswellia AKBA selectively inhibits 5-LOX; Curcumin comparable to diclofenac (Chandran 2012); ar-turmerone co-formulation increases curcumin bioavailability 7× |
| 👁️ Eye Health Stack | ||||
| Macular & Visual Protection | Lutein 10mg (marigold extract), Zeaxanthin 2mg | 60+ | MPOD, visual acuity, glare tolerance, AMD progression, blue-light protection | AREDS2 (n=4,203): Lutein + Zeaxanthin reduced AMD progression by 10–26%; MPOD increases within 12 weeks; protective against screen-related eye fatigue |
| 🫁 Liver & Detox Stack | ||||
| Hepatoprotective Botanicals | Milk Thistle 100mg (Silymarin), Schisandra 100mg (9% schisandrins), Green Tea Extract 75mg (EGCG), Astaxanthin 4mg, Lycopene 10mg | 80+ | ALT/AST liver enzymes, NAFLD scores, oxidative stress markers, hepatocyte protection | Milk Thistle silymarin reduces ALT/AST 15–30 IU/L; Schisandra bridges liver support with adaptogenic activity; EGCG and Astaxanthin are among the most potent dietary antioxidants studied in humans |
| 💊 Micronutrient & Metabolic Foundation | ||||
| Chelated Minerals & Metabolic Support | Magnesium Bisglycinate, Zinc Bisglycinate, Iron Bisglycinate, Chromium Picolinate, Berberine 500mg, Iodine, Manganese, Boron | 180+ | Mineral bioavailability, thyroid function, blood glucose, insulin sensitivity, nerve conduction | Bisglycinate chelation shows 2–4× superior absorption vs oxide/sulfate; Berberine comparable to metformin in glucose RCTs (Yin 2008); Chromium picolinate improves insulin sensitivity; ~50% of North Americans below magnesium RDA (NHANES) |
* Paper counts are estimates of peer-reviewed human clinical literature on PubMed for listed ingredients at comparable doses. Findings do not reproduce any single study and vary by dose, duration, and population. These statements have not been evaluated by the FDA. ThryveOn Vitals is not intended to diagnose, treat, cure, or prevent any disease.
Most supplement brands include ingredients at "label doses" — just enough to print the name. We publish our exact dose alongside the clinical trial dose so you can verify the match yourself.
Key principle: The dose determines whether an ingredient works. An ingredient at 50mg when trials used 600mg is nutritionally meaningless — it looks credible on a label while delivering none of the studied benefit. Every ThryveOn ingredient is dosed at or proportionate to the evidence-validated amount.
| Ingredient | ThryveOn Dose | Clinical Trial Dose | Industry Average | Match |
|---|---|---|---|---|
| Ashwagandha (≥5% withanolides) | 250mg | 125–600mg/day (withanolide-standardised) | 100mg unstandardised | ✓ Standardised dose |
| Lion's Mane (10:1 extract) | 700mg | 500–3,000mg/day | 200–400mg | ✓ At evidence range |
| Rhodiola Rosea (3% rosavins) | 200mg | 170–680mg/day | 50–150mg | ✓ At evidence range |
| CoQ10 | 100mg | 100–300mg/day | 30–60mg | ✓ Full dose |
| Boswellia Serrata (20% AKBA) | 100mg | 100–400mg/day (AKBA-standardised) | 100mg unstandardised | ✓ AKBA standardised |
| Magnesium Bisglycinate | 200mg elemental | 125–300mg elemental | 50mg oxide (4% bio) | ✓ Full dose + superior form |
| MSM | 1,000mg | 1,000–6,000mg/day | 200–500mg | ✓ At evidence range |
| Vitamin D3 | 2,000 IU | 1,000–4,000 IU/day | 400–1,000 IU | ✓ Full dose |
| Saffron | 30mg | 30mg/day | 5–15mg | ✓ Exact clinical dose |
| Lutein | 10mg | 10mg/day (AREDS2) | 2–6mg | ✓ Exact AREDS2 dose |
| Milk Thistle (80% Silymarin) | 150mg | 140–800mg/day | 50–80mg | ✓ At evidence range |
| Berberine HCl | 500mg | 500–1,500mg/day | 100–300mg | ✓ At evidence range |
Two products can list the same ingredient at the same dose. What matters is whether your body can actually absorb and use it. ThryveOn uses only premium bioavailable forms throughout.
Cyanocobalamin must be converted by MTHFR enzyme — impaired in ~40% of North Americans.
~40% of Canadians and Americans carry MTHFR variants that impair folic acid conversion.
MK-7's 72-hour half-life ensures sustained carboxylation of osteocalcin and Matrix-Gla protein for bone and cardiovascular protection.
ar-Turmerone (turmeric essential oil) inhibits intestinal glucuronidation and CYP-mediated metabolism of curcumin, increasing bioavailability approximately 7-fold. ThryveOn's formula also contains 3mg black pepper extract as standard.
ThryveOn Vitals was formulated as a system — not a list. Several ingredients in the formula have documented pharmacological interactions where one actively enhances the mechanism or absorption of another.
D3 upregulates calcium absorption from the gut. K2 MK-7 activates Matrix Gla Protein (MGP) and osteocalcin — the proteins that direct absorbed calcium into bone rather than soft tissue and arterial walls. D3 without K2 risks calcium deposition in the wrong places; together they complete the pathway.
PQQ stimulates mitochondrial biogenesis — the growth of new mitochondria — via PGC-1α activation (Harris 2013). CoQ10 is the electron carrier that fuels those mitochondria in the ETC. PQQ builds the engine; CoQ10 fuels it. Neither achieves the same result alone at these doses.
Standard curcumin has near-zero systemic bioavailability — it is metabolised and excreted before reaching circulation. ar-Turmerone inhibits intestinal glucuronidation and CYP450 enzymes, increasing bioavailability approximately 7×. Black pepper's piperine provides secondary inhibition of the same pathways. Both enhancers act on distinct but complementary metabolic routes.
Both are adaptogens but they act on different aspects of the stress response. Ashwagandha primarily modulates the HPA axis downstream — reducing serum cortisol and upregulating GABA receptor activity. Rhodiola acts upstream at the level of stress-response proteins (HSP70, nitric oxide), improving energy under acute cognitive load. Together they address both chronic cortisol elevation and acute mental fatigue simultaneously.
The methylation cycle converts homocysteine to methionine — a critical process for DNA repair, neurotransmitter synthesis, and cardiovascular health. This reaction requires both 5-MTHF (as the methyl donor) and Methylcobalamin B12 (as the enzyme cofactor). If either is absent or in an unusable form, the cycle stalls and homocysteine accumulates. This is precisely why using standard folic acid or cyanocobalamin breaks the pair — neither can enter the cycle without MTHFR conversion.
Magnesium is a cofactor for GABA synthesis and activates GABA-A receptors, reducing neuronal excitability at night. Glycine independently lowers core body temperature via peripheral vasodilation (Bannai 2012) — one of the primary physiological triggers for sleep onset and slow-wave sleep entry. The two mechanisms are complementary and non-overlapping: Magnesium quiets neural noise; Glycine lowers the thermal threshold for deep sleep.
Lion's Mane drives structural cognitive support — NGF synthesis stimulates neuronal growth and maintenance over weeks to months. L-Theanine provides immediate functional support — inducing alpha-wave activity within 30–45 minutes, promoting focused calm without sedation. The combination addresses both the long-term architecture of cognition and the day-to-day mental state in which cognitive work is performed.
Three immune mechanisms acting in parallel: Zinc supports NK cell activity and is essential for thymulin — the thymic hormone that matures T-cells. Vitamin C stimulates leukocyte production and accumulates in neutrophils at concentrations 50–100× plasma levels during infection. Elderberry anthocyanins directly inhibit virus-host cell binding and stimulate cytokine production. Each targets a different arm of the innate immune response.
Synergy descriptions are mechanistic — they describe documented pharmacological interactions, not claims of treatment or cure. Individual results vary. These statements have not been evaluated by the FDA.
38 landmark human clinical trials underpinning ThryveOn's formulation. Click an ingredient below to filter, or browse all studies. Every card links to its original PubMed publication.
Micronutrients and botanicals work on physiological timescales — not overnight. Here's what the clinical literature suggests at each phase. Individual results vary based on baseline status, diet, and lifestyle.
Probiotics begin colonising the gut (L. Rhamnosus, B. Lactis). Magnesium Bisglycinate starts restoring intracellular magnesium in the ~50% of North Americans who are deficient. Energy and sleep may begin to stabilise. Some users notice reduced bloating and improved digestion. Adaptogens (Ashwagandha, Rhodiola) reach consistent plasma levels.
Ashwagandha begins modulating HPA axis cortisol output — clinical trials show measurable cortisol reduction from week 3. CoQ10 and PQQ begin supporting mitochondrial electron transport chain efficiency. Many users report more stable energy without the mid-afternoon crash. Sleep onset and depth typically improve. Rhodiola anti-fatigue effects are evident during high-demand periods.
Lion's Mane neurological effects become measurable — the Mori 2009 RCT showed significant cognitive function improvement from week 8. Saffron (30mg/day) reaches therapeutic plasma concentrations with mood-stabilising effects comparable to clinical trials. L-Theanine and CDP-Choline have sustained alpha-wave activity improvements. L-Glutamine has substantially reinforced intestinal barrier integrity — gut-brain axis benefits are becoming apparent.
MSM and Boswellia begin demonstrating clinically meaningful joint pain reduction (Boswellia onset 4–8 weeks in clinical trials; MSM knee function at 12 weeks per Kim 2006). Lutein + Zeaxanthin measurably increases macular pigment optical density. Vitamin D3 restores 25-OH-D serum levels — particularly relevant for the 32% of Canadians who are deficient at baseline. Liver enzymes ALT/AST typically trending toward normal in those with elevated baselines (Milk Thistle, Green Tea EGCG, Broccoli sulforaphane).
By 90 days, the Choudhary 2019 RCT shows maximum cognitive and sleep benefits from Ashwagandha. AREDS2 protocol for Lutein showed AMD risk reduction measurable at 5 years. Bone health biomarkers — osteocalcin carboxylation, supported by D3 + K2 MK-7 — become measurable. Berberine and Chromium Picolinate have sustainably improved insulin sensitivity markers. ALCAR and CoQ10 continue compound mitochondrial energy improvements. Ongoing microbiome diversity improvement continues with consistent probiotic use.
Individual results vary. The timeline above is based on published clinical trial outcomes at the doses used in ThryveOn Vitals. Your results depend on your baseline nutritional status, existing deficiencies, sleep, diet, exercise, and other lifestyle factors. These statements have not been evaluated by the FDA or Health Canada. ThryveOn Vitals is not intended to diagnose, treat, cure, or prevent any disease.
Answers to the most common questions about ThryveOn Vitals, written to match how people search and how AI assistants respond to health queries.
